| JTS2400017 | favezelimab帕博利珠单抗注射液 | favezelimab;pembrolizumab | Injection | Biological Products | Disposable Import Drug Application | 2024-03-12 | | Msd Ireland;Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JXSB2101018 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-06-03 | | Msd Ireland;Merck Sharp & Dohme Corp | | | view |
| JXSB2300125 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2023-10-14 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JYSB1900252 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2019-09-13 | Merck Sharp & Dohme Corp. | Merck Sharp & Dohme Corp;Msd Ireland | Certificate Issued | 2019-11-22 | view |
| JXSS2500051 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-04-28 | | Msd Ireland;Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JXSB2300001 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-01-04 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JXSL1800030 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Import Drug Application | 2018-09-12 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd;Merck Sharp & Dohme Corp | Certificate Issued | 2018-10-29 | view |
| JXSB2100007 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(3.1) | Supplementary Application | 2021-01-08 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd;Msd Ireland;Merck Sharp & Dohme Corp | In Review | 2022-01-19 | view |
| JXSS2101033 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-11-26 | | Msd Ireland;Merck Sharp & Dohme Corp;MSD R&D (China) Co Ltd | | | view |
| JYSB2000289 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2020-06-28 | | Msd Ireland;Merck Sharp & Dohme Corp | In Review | 2020-06-25 | view |
| JXSB2101016 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-06-02 | | Msd Ireland;Merck Sharp & Dohme Corp | | | view |
| JYSB2400009 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2024-01-18 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JXSL2000001 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Import Drug Application | 2020-01-16 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd;Merck Sharp & Dohme Corp | In Review | 2020-01-15 | view |
| JXSS2300028 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-03-29 | | Msd Ireland;Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JYSB1800259 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2018-11-28 | | Msd Ireland;Merck Sharp & Dohme Corp | In Review | 2018-11-27 | view |
| JXSL2101109 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-09-14 | | Merck Sharp & Dohme Corp;MSD R&D (China) Co Ltd | | | view |
| JXSB2400095 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2024-07-12 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JXSB2101078 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-10-26 | | Msd Ireland;Merck Sharp & Dohme Corp | | | view |
| JXSB2000034 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2020-10-21 | 默沙东研发（中国）有限公司 | MSD R&D (China) Co Ltd;Msd Ireland;Merck Sharp & Dohme Corp | In Review | 2020-10-20 | view |
| JXSL2101151 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-12-24 | | Merck Sharp & Dohme Corp;MSD R&D (China) Co Ltd | | | view |
